Design and synthesis of some benzothiazole hybrids as VEGFR-2-targeting anti-prostate cancer agents and their computational studies
= 36.6 nM) compared to sorafenib. Molecular docking against VEGFR-2 (PDB ID: 3VHE) revealed that compounds 7f-7i showed better binding energies and inhibition constants than sorafenib. Interestingly, the binding energies and inhibition constants of 7f and 7g were found to be consistent with the VEGFR-2 inhibition data. Finally, the DFT investigation of 7f revealed a conjugated donor-π-acceptor system with good charge transfer properties. The negative electrostatic potential of carbonyl oxygen suggests possible interactions with VEGFR-2.
Authors
- Khushal M. Kapadiya (ORCID: https://orcid.org/0000-0001-5041-1228)
- Siddhartha Marupati (ORCID: https://orcid.org/0000-0002-0163-6209)
- Bonny Y. Patel (ORCID: https://orcid.org/0000-0002-7017-7026)
- Rahul Talaviya
- G. Naaresh Reddy
- Ramana Gujjula
Institutions
- RK University (IN)
- Vardhaman College of Engineering (IN)
Publication Details
- Journal
- RSC Advances
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1039/d6ra07735h
- Primary Topic
- Heterocyclic Compound Synthesis and Bioactivity
- Type
- article
- Field-Weighted Citation Impact
- 0.00